Buy JK Cement, target Rs 330: Sharekhan

Published on Wed, Dec 05, 2007 at 12:24 |  Source : Moneycontrol.com

Updated at Wed, Dec 05, 2007 at 13:07  

5392 Investors following JK Cement. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Sharekhan Stock Broking firm has maintianed buy rating on JK Cement with target price of Rs 330, as per their report on December 04, 2007.  "Considering the higher than expected earnings for the current quarter, we are upgrading our earnings estimates for FY2008 by 19% to Rs 35.7 per share and that for FY2009 by 12% to Rs 28.1 per share. We have been bullish on the business prospects of JK Cement on account of its cost-cutting measures and its capex programme. Savings in power cost from the CPPs and higher volumes from its greenfield facility will be the major business drivers for the stock. The stock is trading at 10x its earnings and 6.6x its EV/EBITDA on FY2009 earnings estimate. It commands an EV per tonne of USD 84, which is lower than the benchmark asset valuation of USD 100-115 per tonne. Considering the cheap asset valuations, we maintain our Buy recommendation on the stock with an upgraded price target of Rs 330 per share, leaving an upside of 30%" according to Sharekhan report.

 

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decision.

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

CNBC-TV18 ALERT HSBC-Adani Circular Trading Case Can't Be Accepted

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!